[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1981

Factors Influencing Outcome of Kidney Allografts From Pretreated Cadaveric Donors

Author Affiliations

From the Mayo Clinic and Mayo Foundation, Rochester, Minn.

Arch Surg. 1981;116(1):73-77. doi:10.1001/archsurg.1981.01380130049011
Abstract

• A five-year retrospective analysis of patient and graft survival after initial cadaveric kidney transplantation showed that recipients of kidneys from cadaveric donors pretreated with cyclophosphamide (Cytoxan) and methylprednisolone (Medrol) had better graft survival than those patients who received nonpretreated kidneys. In patients not receiving transfusions, transplantation of a pretreated kidney improved the chances of success, with graft survival equivalent to that for patients receiving transfusions. Splenectomy was beneficial for graft survival and did not affect overall patient survival. The effect of splenectomy could not be clearly separated from the effect of donor pretreatment.

(Arch Surg 116:73-77, 1981)

×